ATI RN
CNS Drugs Pharmacology PDF Questions
Question 1 of 5
The following antiepileptic drug is also effective in manic-depressive illness
Correct Answer: D
Rationale: In the context of CNS drugs pharmacology, understanding the dual therapeutic effects of certain medications is crucial. In this case, the correct answer is D) Carbamazepine. Carbamazepine is not only an antiepileptic drug but also demonstrates efficacy in treating manic-depressive illness, also known as bipolar disorder. This dual mechanism of action makes carbamazepine a valuable option for patients presenting with both conditions. Now, let's examine why the other options are incorrect: A) Ethosuximide: Ethosuximide is primarily used in the treatment of absence seizures and is not indicated for manic-depressive illness. B) Primidone: Primidone is another antiepileptic drug, mainly used for generalized tonic-clonic and partial seizures. It is not typically employed in the management of manic-depressive illness. C) Phenobarbitone: Phenobarbital is an older antiepileptic drug with sedative properties. It is not commonly used in the treatment of manic-depressive illness due to its side effect profile and limited efficacy in mood disorders. Educational context: Understanding the diverse pharmacological actions of CNS drugs is essential for healthcare professionals managing patients with neurological and psychiatric conditions. Recognizing the dual therapeutic effects of certain medications, like carbamazepine in this case, can optimize treatment outcomes and patient care. It underscores the importance of a comprehensive understanding of pharmacology in clinical practice.
Question 2 of 5
Nitrous oxide is
Correct Answer: D
Rationale: Nitrous oxide is a gas used in anesthesia due to its unique properties. The correct answer, D) All of the above, is accurate because nitrous oxide is indeed non-flammable, making it a safe option for use in medical settings. It is also non-irritant, meaning it does not cause irritation or damage to the respiratory tract during administration. Furthermore, nitrous oxide is a potent analgesic, offering pain relief without inducing unconsciousness. Option A) Non-flammable, is incorrect as nitrous oxide is flammable in high concentrations, but in medical settings, it is used in a diluted form which is non-flammable. Option B) Non-irritant, is incorrect as it can cause irritation in high concentrations or when administered improperly. Option C) Potent analgesic, is incorrect as nitrous oxide alone is not a potent analgesic but when combined with other agents, it enhances their analgesic effects. In an educational context, understanding the properties of nitrous oxide is crucial for healthcare professionals, especially anesthesiologists and nurses, who administer it. Knowing that it is non-flammable, non-irritant, and a moderate analgesic helps ensure safe and effective use in clinical practice, highlighting the importance of accurate drug knowledge for patient care and safety.
Question 3 of 5
The psychotic symptoms most benefited by neuroleptic drugs are
Correct Answer: C
Rationale: In pharmacology, neuroleptic drugs, also known as antipsychotics, are primarily used to treat psychotic symptoms associated with conditions like schizophrenia. The correct answer is option C) Hallucinations, delusions, and aggression because neuroleptic drugs target these specific symptoms by blocking dopamine receptors in the brain, thus reducing the severity of hallucinations, delusions, and aggressive behaviors. Option A) Judgment and memory impairment is incorrect because neuroleptic drugs do not directly target or significantly improve these cognitive functions. While some side effects of these drugs may impact cognition, that is not their primary therapeutic effect. Option B) Loss of insight and volition is incorrect because although neuroleptic drugs may help reduce some symptoms related to insight and volition in the context of psychotic disorders, these are not the primary symptoms targeted by these medications. Option D) Apathy and social withdrawal is incorrect because neuroleptic drugs are not specifically designed to address these symptoms. Apathy and social withdrawal are more often associated with other conditions such as depression or certain personality disorders, which may require different treatment approaches. In an educational context, understanding the specific target symptoms of neuroleptic drugs is crucial for healthcare professionals working with patients experiencing psychotic disorders. By knowing which symptoms these medications are most effective at addressing, clinicians can make informed decisions regarding treatment plans to optimize patient outcomes and quality of life.
Question 4 of 5
A 30-year-old woman suffering from endogenous depression improved after one month of treatment with amitriptyline. How long should the drug be continued?
Correct Answer: B
Rationale: The correct answer is B) Chlorgiline. Chlorgiline is a type of irreversible monoamine oxidase inhibitor (MAOI) used in the treatment of depression. In the scenario provided, the patient improved after one month of treatment with amitriptyline, indicating a positive response to antidepressant therapy. Since endogenous depression often requires long-term treatment to prevent relapse, switching to an MAOI like chlorgiline would be appropriate for maintenance therapy. Option A) Selegiline is a selective MAO-B inhibitor primarily used in the treatment of Parkinson's disease and not typically indicated for depression. Option C) Moclobemide is a reversible MAOI that may be used in the treatment of depression, but chlorgiline is a more suitable option for long-term maintenance therapy. Option D) Tranylcypromine is another type of MAOI, but chlorgiline is a better choice for maintenance therapy due to its irreversible nature. In an educational context, understanding the mechanisms of action and appropriate use of different classes of antidepressants is crucial for effective pharmacological treatment of depression. It is important for healthcare professionals to be able to differentiate between various antidepressants to tailor treatment plans to individual patient needs and optimize outcomes.
Question 5 of 5
Which of the following drugs improves some symptoms in Alzheimer's dementia by increasing brain acetylcholine levels?
Correct Answer: B
Rationale: The correct answer is B) Tacrine. Tacrine is a centrally acting cholinesterase inhibitor that helps improve some symptoms in Alzheimer's dementia by increasing brain acetylcholine levels. Acetylcholine is a neurotransmitter that plays a crucial role in memory and learning. By inhibiting the breakdown of acetylcholine, tacrine enhances cholinergic transmission, which can help alleviate cognitive decline in Alzheimer's patients. Now, let's discuss why the other options are incorrect: A) Pemoline: Pemoline is a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It does not have a direct impact on acetylcholine levels in the brain and is not indicated for Alzheimer's dementia. C) Nicergoline: Nicergoline is a drug used to improve symptoms of cognitive impairment and dementia, but it works through different mechanisms such as enhancing cerebral blood flow and oxygen utilization. It does not directly increase brain acetylcholine levels like cholinesterase inhibitors. D) Piribedil: Piribedil is a dopamine agonist primarily used in the treatment of Parkinson's disease. It does not target acetylcholine levels in the brain and is not indicated for Alzheimer's dementia treatment. In an educational context, understanding the mechanisms of action of CNS drugs is crucial for healthcare professionals involved in the care of patients with neurological disorders. Knowing how each drug works allows for appropriate selection based on the underlying pathology. In the case of Alzheimer's dementia, cholinesterase inhibitors like tacrine are valuable in managing cognitive symptoms by addressing the neurotransmitter imbalance in the brain.